Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/21/2009CN101559053A 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
10/21/2009CN101559052A Oral pharmaceutical composition containing mitiglinide and voglibose
10/21/2009CN101559051A Use of butin and derivatives thereof for preparing drugs having inhibitive effect on melanoma
10/21/2009CN101559050A Use of butin and derivatives thereof for preparing drugs having inhibitive effect on immune system
10/21/2009CN101559049A Hepatic fibrosis inhibitor
10/21/2009CN101559048A Application of hypnopyrine to the preparation of 2-type antidiabetic drugs
10/21/2009CN101559047A Function of xylitol erythritol in wound irrigation
10/21/2009CN101559046A Therapeutic action of micromolecule sugar alcohol composite on nasal disease
10/21/2009CN101559045A Arachidonic acid nutrition microcapsule with high temperature resistance and preparation method thereof
10/21/2009CN101559044A Clopidogrel hydrosulfate enteric coated tablet and preparation thereof
10/21/2009CN101559043A Benzene sulfonic acid levo-amlodipine pill and preparation method thereof
10/21/2009CN101559042A Compound double-layer tablet containing telmisartan and hydrochlorothiazide
10/21/2009CN101559040A Medicament composition of cefotiam hydrochloride and preparation thereof
10/21/2009CN101559038A Solid lipid nanoparticles of finasteride and preparation method thereof
10/21/2009CN101559037A Binary solution type preparation for intravenous injection and intracerebral injection
10/21/2009CN101559035A Plant extract composition for killing fungi, preparation method thereof and application in preparing antifungal products
10/21/2009CN100551928C M-crystal type of adefovir dipivoxil ester and preparation method and medicine application
10/21/2009CN100551924C 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/21/2009CN100551921C Use of brasilein
10/21/2009CN100551916C Novel 2,4-diamino-1,3,5-triazine derivative
10/21/2009CN100551915C 8-chloro-2,3-benzodiazepine derivatives
10/21/2009CN100551911C Polyphenols compound modified by azo-containing heterocyclic and use thereof
10/21/2009CN100551910C Styryl compound modified by azo-containing heterocyclic and use thereof
10/21/2009CN100551907C Compound in category of aryl methylamino dithio formic ether, preparation method and application
10/21/2009CN100551901C Method for preparing magnesium aspartate
10/21/2009CN100551900C Method for preparing potassium aspartate
10/21/2009CN100551445C Self assembled precusor liposome containing hard soluble medicine and its preparation method
10/21/2009CN100551442C Medicinal composition containing calcium passage paralysor and B family vitamin and its use
10/21/2009CN100551410C Antidepressive medicine and its preparation method
10/21/2009CN100551400C Medicine for treating bronchitis and asthma
10/21/2009CN100551395C Traditional Chinese medicine for treating exogenous injury of human body
10/21/2009CN100551394C Medicine for treating psoriasis
10/21/2009CN100551392C Decumbent corydalis Rhizome medicinal composition for treating cerebral thrombosis sequela and rheumatic arthritis
10/21/2009CN100551388C An injection containing phenylpropanolid glycosides, its preparation method and use
10/21/2009CN100551386C Dry coating sustained-release tablet for treating arthritis and preparation process thereof
10/21/2009CN100551385C Externally used traditional Chinese medicine and its preparing process
10/21/2009CN100551384C Plaster for treating hyperosteogeny, neuro-pain and various kinds of inflammation
10/21/2009CN100551380C Bacteriostat-free water-soluble vitamin freeze-dried preparation for injection
10/21/2009CN100551379C Application of centella triterpenes in the preparing of medicine for preventing and curing kidney fibrosis
10/21/2009CN100551378C Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac
10/21/2009CN100551377C Bisphosphonic acid for the treatment and prevention of osteoporosis
10/21/2009CN100551376C Antibiotic slow-release preparation for local use
10/21/2009CN100551375C Use of 23-hydroxy betutic acid in preparing medicine for treating and preventing glioma
10/21/2009CN100551374C Sterilization technology of prostadil fatty emulsion and method of determination
10/21/2009CN100551373C Buspirone hydrochloride slow/controlled release micro pill
10/21/2009CN100551372C A combination of medication and application in preparing medication for treating and preventing cardiovascular diseases and cerebrovascular disease
10/21/2009CN100551371C Zirasitone mesylate soluble medicinal preparation
10/21/2009CN100551370C Use of Ranolazine in preparing pharmaceutical composition for treating diabetes
10/21/2009CN100551369C Sustained release preparation containing cilostazol and its preparation method
10/21/2009CN100551368C Ciclopirox olamine gelling agent, method for preparing the same and pharmaceutical use thereof
10/21/2009CN100551367C Use of chloride 13-hexyl berberine and chloride 13-hexyl palmatine in preparation of medicine for treating vagina infection-inflammation
10/21/2009CN100551366C Use of atractylone in preparing influenza virus resisting medicine
10/21/2009CN100551365C Method for preparing submicron particles of taxol
10/21/2009CN100551364C Medicine use of 3 (3 nitryl-4-hydroxy)phenyl acrylate in preparing medicine for controlling xanthine oxidase
10/21/2009CN100551363C A solid dosage form comprising a fibrate
10/21/2009CN100551358C Method for making particles for use in a pharmaceutical composition
10/21/2009CN100551355C Compound three-segment plug of hydrochloric acid amodiaquine and artesunate
10/21/2009CA2629547A1 Compositions of phosphodiesterase type iv inhibitors
10/20/2009US7605289 N-Benzyl-N-methyl-4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)benzamide; modulating activity of hydroxysteroid dehydrogenases (HSDs), 11 beta-hydroxysteroid dehydrogenases,(also; 17 beta-, 20 alpha-, and 3 alpha-); antidiabetic agents;, obesity, glaucoma, osteoporosis, cognitive disorders; immunotherapy
10/20/2009US7605282 Process for the preparation of an oxaliplatin preparation
10/20/2009US7605274 precipitating crystalline form from solvent solution using water as an antisolvent
10/20/2009US7605273 P38 map kinase inhibitors; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure
10/20/2009US7605272 N-{2-[2-(1H-indazol-3-yl)vinyl]-5-(4-methylpiperazin-1-ylmethyl)phenyl}-3-methylthiophene-2-carboxamide; type I insulin-like growth factor receptor inhibitors; anticarcinognenic agents; colon, pancreatic cancers; antitumor agents; hematopoietic tumors; industrial scale
10/20/2009US7605269 4-[5-(1,1,2-Trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pentalen-4-yl)-[1,2,4]oxadiazol-3-yl]-phenol; G protein-coupled receptor S1P1/EDG1 (endothelial differentiation gene); new immunosuppressant; side effect reduction; transplant rejection; autoimmune diseases; antiinflammatory agents
10/20/2009US7605264 Nitrogen-containing tetracylic bridged ring compounds; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB)
10/20/2009US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
10/20/2009US7605260 Process for producing imide compound
10/20/2009US7605258 Preparing an individual isomer of mono-pegylated rapamycin 42 ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) by reacting an isomer of rapamycin with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid; use in treating nerve system cancer, leukemia, breast cancer, prostate cancer
10/20/2009US7605252 siRNA targeting kinase insert domain receptor (KDR)
10/20/2009US7605251 an RNA strand (the antisense strand) having a region which is less than 30 nucleotides in length, complementary to at least a part of the PCSK9 gene; antihyperlipemia agent
10/20/2009US7605249 To deliver specifically tailored small interfering RNA as therapeutic agents for treatment of Parkinson's disease
10/20/2009US7605246 Genes differentially expressed in breast cancer
10/20/2009US7605185 Treatment of arrhythmia by retinoids affecting signal transduction
10/20/2009US7605184 Method of anesthesia
10/20/2009US7605183 Using 4,4-dimethyl-6-methylene-2-cyclohexen -1-one
10/20/2009US7605182 Compounds that selectively bind to membranes of apoptotic cells
10/20/2009US7605181 Method for the treatment of metabolic disorders
10/20/2009US7605180 Release preparation useful as an antidiabetic, a nateglinide-containing wherein the nateglinide is amorphous.
10/20/2009US7605179 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles
10/20/2009US7605178 Therapeutic compounds
10/20/2009US7605177 protect neural cells from degeneration and/or death in response to traumatic brain injury or autoimmune disorders of the brain, such as multiple sclerosis and in reducing seizures; hypoxia/ischemia, toxic injury, and chronic neurodegenerative disorders including Parkinson's disease
10/20/2009US7605176 β-ketoamide compounds with MCH antagonistic activity
10/20/2009US7605175 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
10/20/2009US7605174 Indane derivatives as modulators of ion channels
10/20/2009US7605173 Pharmaceutical liquid composition containing pyridone derivative
10/20/2009US7605172 Plasminogen activator inhibitor-1 (PAI-1) modulators; 3-phenyl-2-{[6-(2-phenyl-1,3-thiazol-4-yl)-2-naphthyl]oxy}propanoic acid; thrombosis; cardiovascular disease
10/20/2009US7605171 (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
10/20/2009US7605170 8-azabicyclo[3.2.1]octane derivatives
10/20/2009US7605169 Antibacterial agents
10/20/2009US7605168 PDE4B inhibitors
10/20/2009US7605167 Use of cyclopamine in the treatment of psoriasis
10/20/2009US7605166 Synergistic mixture of methotrexate and integrin antigen or antibody
10/20/2009US7605165 Phenylalanine derivatives
10/20/2009US7605164 Compositions and methods for treating heart failure
10/20/2009US7605163 Benzoyl-piperazine derivatives
10/20/2009US7605162 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; high affinity for both the dopamine D2 receptor and the serotonin reuptake site; nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia
10/20/2009US7605161 Pyridyl derivatives and their use as therapeutic agents
10/20/2009US7605160 Inhibit tyrosine kinase activity of Trk receptors; antiproliferative agents, anticancer agents; cancer, psoriasis or rheumatoid arthritis; N4-pyrazol-5-yl-pyrrolo[2,1-f] [1,2,4]triazine-2,4-diamines
10/20/2009US7605159 Cathepsin cysteine protease inhibitors and their use
10/20/2009US7605158 Carbamoyl-type benzofuran derivatives
1 ... 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 ... 7860